| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 92.69B | 91.06B | 85.90B | 77.71B | 72.70B | 66.91B |
| Gross Profit | 20.37B | 20.13B | 19.41B | 17.38B | 16.85B | 16.01B |
| EBITDA | 2.80B | 2.77B | 2.89B | 2.15B | 2.46B | 2.28B |
| Net Income | 1.09B | 1.05B | 1.34B | 358.19M | 798.55M | 858.21M |
Balance Sheet | ||||||
| Total Assets | 23.68B | 24.33B | 23.90B | 22.22B | 21.59B | 19.39B |
| Cash, Cash Equivalents and Short-Term Investments | 3.99B | 4.78B | 4.90B | 3.51B | 3.62B | 2.62B |
| Total Debt | 3.11B | 3.34B | 4.00B | 5.09B | 4.68B | 3.63B |
| Total Liabilities | 12.02B | 13.13B | 13.54B | 13.14B | 12.73B | 11.26B |
| Stockholders Equity | 11.66B | 11.20B | 10.36B | 9.07B | 8.85B | 8.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.34B | 2.76B | 206.70M | 576.46M | 747.23M |
| Operating Cash Flow | 0.00 | 1.90B | 3.46B | 1.28B | 1.56B | 1.66B |
| Investing Cash Flow | 0.00 | -810.80M | -698.79M | -1.34B | -1.07B | -997.13M |
| Financing Cash Flow | 0.00 | -1.21B | -1.37B | -47.35M | 526.74M | -1.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥16.41B | 7.47 | ― | 1.48% | 5.86% | -16.20% | |
74 Outperform | ¥18.66B | 10.84 | ― | 2.12% | 12.92% | -30.67% | |
73 Outperform | ¥12.40B | 7.01 | ― | 2.30% | 10.43% | 12.10% | |
67 Neutral | ¥11.01B | 8.96 | ― | 1.45% | -0.02% | -7.09% | |
66 Neutral | ¥31.93B | 14.62 | ― | 2.22% | 7.94% | -8.55% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
51 Neutral | ¥12.62B | 29.59 | ― | 2.32% | 2.43% | 50.53% |